19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fiorella Ilariucci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 42 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

Mauro, F. R., Molica, S., Soddu, S., Ilariucci, F., Coscia, M., Zaja, F., Angelucci, E., Re, F., Liberati, A. M., Tedeschi, A., Reda, G., Pietrasanta, D., Gozzetti, A., Battistini, R., Del Poeta, G., Musolino, C., Nanni, M., Piciocchi, A., Vignetti, M., Neri, A. & 8 others, Albano, F., Cuneo, A., Giudice, I. D., Starza, I. D., de Propris, M. S., Raponi, S., Guarini, A. R. & Foà, R., May 1 2020, In : Haematologica. 105, 5

Research output: Contribution to journalArticle

Open Access

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum, Jul 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

Research output: Contribution to journalArticle

  • Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    GIMEMA, European Research Initiative on CLL (ERIC) & UK CLL forum, Jul 3 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

    Research output: Contribution to journalArticle

  • Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

    Research output: Contribution to journalArticle

    Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

    Research output: Contribution to journalArticle